Es gab 50 kürzliche Insider-Transaktionen für Adial Pharmaceuticals, Inc. (ADIL), darunter 46 Käufe und 1 Verkauf. Die gesamten Insider-Käufe beliefen sich auf $2.6M und die gesamten Insider-Verkäufe auf RSU Award.
Bedeutende Insider mit kürzlicher Aktivität umfassen Claiborne Cary J, Goodman Tony, Anderson J. Kermit. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — ADIL
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2025-05-29 |
Claiborne Cary J |
Chief Executive Officer |
RSU-Zuteilung |
138,000 |
$0.69 |
$94.94K |
138,000 |
| 2025-05-29 |
Goodman Tony |
Chief Operating Officer |
RSU-Zuteilung |
94,000 |
$0.69 |
$64.67K |
94,000 |
| 2025-05-29 |
Anderson J. Kermit |
Director |
RSU-Zuteilung |
28,000 |
$0.69 |
$19.26K |
28,000 |
| 2025-05-29 |
Schuyler Kevin |
Director |
RSU-Zuteilung |
28,000 |
$0.69 |
$19.26K |
28,000 |
| 2025-05-29 |
Gilliland Robertson H. |
Director |
RSU-Zuteilung |
28,000 |
$0.69 |
$19.26K |
28,000 |
| 2025-05-29 |
Newman James W. Jr. |
Director |
RSU-Zuteilung |
28,000 |
$0.69 |
$19.26K |
28,000 |
| 2025-05-29 |
Shah Vinay |
Chief Financial Officer |
RSU-Zuteilung |
9,000 |
$0.69 |
$6.19K |
9,000 |
| 2024-12-05 |
Claiborne Cary J |
Chief Executive Officer |
RSU-Zuteilung |
350,000 |
$1.15 |
$402.5K |
350,000 |
| 2024-11-16 |
Shah Vinay |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-11-16 |
Shah Vinay |
Chief Financial Officer |
RSU-Zuteilung |
40,000 |
$1.06 |
$42.4K |
40,000 |
| 2024-03-25 |
Claiborne Cary J |
Chief Executive Officer |
RSU-Zuteilung |
60,000 |
$1.35 |
$81K |
60,000 |
| 2024-03-25 |
Goodman Tony |
Chief Operating Officer |
RSU-Zuteilung |
42,000 |
$1.35 |
$56.7K |
42,000 |
| 2024-03-25 |
Anderson J. Kermit |
Director |
RSU-Zuteilung |
12,000 |
$1.35 |
$16.2K |
12,000 |
| 2024-03-25 |
Truluck Joseph |
Chief Financial Officer |
RSU-Zuteilung |
25,000 |
$1.35 |
$33.75K |
25,000 |
| 2024-03-25 |
Schuyler Kevin |
Director |
RSU-Zuteilung |
12,000 |
$1.35 |
$16.2K |
12,000 |
| 2024-03-25 |
Gilliland Robertson H. |
Director |
RSU-Zuteilung |
12,000 |
$1.35 |
$16.2K |
12,000 |
| 2024-03-25 |
Newman James W. Jr. |
Director |
RSU-Zuteilung |
12,000 |
$1.35 |
$16.2K |
12,000 |
| 2023-09-29 |
Schuyler Kevin |
Director |
Informierter Kauf |
700 |
$2.74 |
$1.92K |
700 |
| 2023-05-23 |
Claiborne Cary J |
Chief Executive Officer |
RSU-Zuteilung |
300,000 |
$0.30 |
$90.75K |
300,000 |
| 2023-05-23 |
Goodman Tony |
Director |
RSU-Zuteilung |
50,000 |
$0.30 |
$15.13K |
50,000 |
| 2023-05-23 |
Anderson J. Kermit |
Director |
RSU-Zuteilung |
50,000 |
$0.30 |
$15.13K |
50,000 |
| 2023-05-23 |
Stilley William B. Iii |
Director |
RSU-Zuteilung |
50,000 |
$0.30 |
$15.13K |
50,000 |
| 2023-05-23 |
Truluck Joseph |
Chief Financial Officer |
RSU-Zuteilung |
125,000 |
$0.30 |
$37.81K |
125,000 |
| 2023-05-23 |
Schuyler Kevin |
Director |
RSU-Zuteilung |
50,000 |
$0.30 |
$15.13K |
50,000 |
| 2023-05-23 |
Gilliland Robertson H. |
Director |
RSU-Zuteilung |
50,000 |
$0.30 |
$15.13K |
50,000 |
| 2023-05-23 |
Newman James W. Jr. |
Director |
RSU-Zuteilung |
50,000 |
$0.30 |
$15.13K |
50,000 |
| 2023-05-23 |
Johnson Bankole A. |
Director |
RSU-Zuteilung |
40,000 |
$0.30 |
$12.1K |
40,000 |
| 2022-12-30 |
Stilley William B. Iii |
Director |
Aktienrückgabe |
166,667 |
- |
- |
1,020,979 |
| 2022-09-20 |
Claiborne Cary J |
Chief Executive Officer |
RSU-Zuteilung |
75,000 |
$0.42 |
$31.52K |
1,100,000 |
| 2022-09-19 |
Claiborne Cary J |
Chief Executive Officer |
RSU-Zuteilung |
25,000 |
$0.43 |
$10.74K |
1,025,000 |
| 2022-08-22 |
Stilley William B. Iii |
Director |
RSU-Zuteilung |
100,000 |
$0.56 |
$55.5K |
100,000 |
| 2022-08-18 |
Claiborne Cary J |
Chief Executive Officer |
RSU-Zuteilung |
1,000,000 |
- |
- |
1,000,000 |
| 2022-06-27 |
Goodman Tony |
Director |
RSU-Zuteilung |
25,000 |
- |
- |
25,000 |
| 2022-02-23 |
Claiborne Cary J |
Chief Operating Officer |
RSU-Zuteilung |
6,667 |
$2.00 |
$13.33K |
6,667 |
| 2022-02-23 |
Goodman Tony |
Director |
RSU-Zuteilung |
40,000 |
$2.00 |
$80K |
40,000 |
| 2022-02-23 |
Anderson J. Kermit |
Director |
RSU-Zuteilung |
40,000 |
$2.00 |
$80K |
40,000 |
| 2022-02-23 |
Stilley William B. Iii |
Chief Executive Officer |
RSU-Zuteilung |
250,000 |
- |
- |
1,187,646 |
| 2022-02-23 |
Truluck Joseph |
Chief Financial Officer |
RSU-Zuteilung |
100,000 |
$2.00 |
$200K |
100,000 |
| 2022-02-23 |
Schuyler Kevin |
Director |
RSU-Zuteilung |
40,000 |
$2.00 |
$80K |
40,000 |
| 2022-02-23 |
Johnson Bankole A. |
Chief Medical Officer |
RSU-Zuteilung |
35,000 |
$2.00 |
$70K |
35,000 |
| 2022-02-23 |
Gilliland Robertson H. |
Director |
RSU-Zuteilung |
40,000 |
$2.00 |
$80K |
40,000 |
| 2022-02-23 |
Newman James W. Jr. |
Director |
RSU-Zuteilung |
40,000 |
$2.00 |
$80K |
40,000 |
| 2021-12-30 |
Newman James W. Jr. |
Director |
Informierter Kauf |
10,000 |
$2.66 |
$26.6K |
20,000 |
| 2021-12-23 |
Schuyler Kevin |
10 Percent Owner |
Schenkung (gegeben) |
90,000 |
$6.25 |
$562.5K |
- |
| 2021-12-07 |
Claiborne Cary J |
Chief Operating Officer |
RSU-Zuteilung |
130,000 |
$2.77 |
$360.1K |
130,000 |
| 2021-11-30 |
Stilley William B. Iii |
10 Percent Owner, Officer: Chief Executive Officer |
Informierter Kauf |
10,600 |
$2.75 |
$29.18K |
937,646 |
| 2021-11-29 |
Stilley William B. Iii |
10 Percent Owner, Officer: Chief Executive Officer |
Informierter Kauf |
10,000 |
$2.59 |
$25.89K |
927,046 |
| 2021-11-26 |
Newman James W. Jr. |
Director |
Informierter Kauf |
10,000 |
$2.85 |
$28.5K |
34,475 |
| 2021-11-02 |
Claiborne Cary J |
Director |
Unbekannt |
- |
- |
- |
- |
| 2021-11-02 |
Claiborne Cary J |
Director |
RSU-Zuteilung |
60,000 |
$3.15 |
$189K |
60,000 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
